Literature DB >> 27573148

[The selective waiving of neoadjuvant (chemo)radiotherapy for rectal cancer lacks evidence].

D Habermehl1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27573148     DOI： 10.1007/s00104-016-0279-x

Source DB:  PubMed          Journal:  Chirurg        ISSN： 0009-4722            Impact factor:   0.955


× No keyword cloud information.
  16 in total

Review 1.  Individualized radiotherapy by combining high-end irradiation and magnetic resonance imaging.

Authors:  Stephanie E Combs; Fridtjof Nüsslin; Jan J Wilkens
Journal:  Strahlenther Onkol       Date:  2016-02-06       Impact factor: 3.621

2.  [S3-guideline colorectal cancer version 1.0].

Authors:  C Pox; S Aretz; S C Bischoff; U Graeven; M Hass; P Heußner; W Hohenberger; A Holstege; J Hübner; F Kolligs; M Kreis; P Lux; J Ockenga; R Porschen; S Post; N Rahner; A Reinacher-Schick; J F Riemann; R Sauer; A Sieg; W Scheppach; W Schmitt; H J Schmoll; K Schulmann; A Tannapfel; W Schmiegel
Journal:  Z Gastroenterol       Date:  2013-08-16       Impact factor: 2.000

Review 3.  MRI-based treatment of rectal cancer: is prognostication of the recurrence risk solid enough to render radiation redundant?

Authors:  Marie-Luise Sautter-Bihl; Werner Hohenberger; Rainer Fietkau; Claus Roedel; Heinz Schmidberger; Rolf Sauer
Journal:  Ann Surg Oncol       Date:  2013-09-04       Impact factor: 5.344

4.  The predictive value of 18F-FDG PET/CT for assessing pathological response and survival in locally advanced rectal cancer after neoadjuvant radiochemotherapy.

Authors:  Lucia Leccisotti; Maria Antonietta Gambacorta; Chiara de Waure; Antonella Stefanelli; Brunella Barbaro; Fabio Maria Vecchio; Claudio Coco; Roberto Persiani; Antonio Crucitti; Antonino Pio Tortorelli; Alessandro Giordano; Vincenzo Valentini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-02-17       Impact factor: 9.236

5.  Prognostic groups in 1,676 patients with T3 rectal cancer treated without preoperative radiotherapy.

Authors:  Morten T Eriksen; Arne Wibe; Jon Haffner; Johan N Wiig
Journal:  Dis Colon Rectum       Date:  2007-02       Impact factor: 4.585

6.  Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years.

Authors:  Rolf Sauer; Torsten Liersch; Susanne Merkel; Rainer Fietkau; Werner Hohenberger; Clemens Hess; Heinz Becker; Hans-Rudolf Raab; Marie-Therese Villanueva; Helmut Witzigmann; Christian Wittekind; Tim Beissbarth; Claus Rödel
Journal:  J Clin Oncol       Date:  2012-04-23       Impact factor: 44.544

7.  Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04.

Authors:  Samuel Y Ngan; Bryan Burmeister; Richard J Fisher; Michael Solomon; David Goldstein; David Joseph; Stephen P Ackland; David Schache; Bev McClure; Sue-Anne McLachlan; Joseph McKendrick; Trevor Leong; Cris Hartopeanu; John Zalcberg; John Mackay
Journal:  J Clin Oncol       Date:  2012-09-24       Impact factor: 44.544

8.  [Role of neoadjuvant radiotherapy for rectal cancer : Is MRI-based selection a future model?].

Authors:  Y Kulu; T Hackert; J Debus; M-A Weber; M W Büchler; A Ulrich
Journal:  Chirurg       Date:  2016-07       Impact factor: 0.955

9.  Reduced toxicity in the treatment of locally advanced rectal cancer: a comparison of volumetric modulated arc therapy and 3D conformal radiotherapy.

Authors:  Leif Hendrik Dröge; Hanne Elisabeth Weber; Manuel Guhlich; Martin Leu; Lena-Christin Conradi; Jochen Gaedcke; Steffen Hennies; Markus Karl Herrmann; Margret Rave-Fränk; Hendrik Andreas Wolff
Journal:  BMC Cancer       Date:  2015-10-20       Impact factor: 4.430

10.  Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial.

Authors:  David Sebag-Montefiore; Richard J Stephens; Robert Steele; John Monson; Robert Grieve; Subhash Khanna; Phil Quirke; Jean Couture; Catherine de Metz; Arthur Sun Myint; Eric Bessell; Gareth Griffiths; Lindsay C Thompson; Mahesh Parmar
Journal:  Lancet       Date:  2009-03-07       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.